Bart Rossel
InvestorScientific Advisor and Advisory Board Member, Novalis Biotech Incubation Fund; Supervisory Board Member of Novalis at Novalis Biotech
About
Bart Rossel is a bio-engineer by training who has worked in the agro and life science sectors and held several management roles. In 2002, he and his team acquired the pharmaceutical company Oystershell Laboratories, which they sold to Gilde Buy Out Partners in 2017. He holds several patents and authored a book about insects.
Invests in
BiotechConsumer
Colleagues at Novalis Biotech
Cedric Bogaert
Entrepreneur in Residence - managing myNEO at Novalis Biotech
Jan Van den Berghe
Co-Founder / Managing Director at Novalis Biotech
Jaroslav Belotserkovsky
Investment Manager at Novalis Biotech
Kathleen Van den Berghe
Member of the Supervisory Board at Novalis Biotech
Kjell Mortier
Fund Manager at Novalis Biotech
Liesbeth Ceelen
Advisory board member at Novalis Biotech
Michael Hengartner
Advisory board member at Novalis Biotech
Wim Van Criekinge
Co-Founder / Managing Director at Novalis Biotech
Frequently asked questions
- Who is Bart Rossel?
- Bart Rossel is a bio-engineer by training who has worked in the agro and life science sectors and held several management roles. In 2002, he and his team acquired the pharmaceutical company Oystershell Laboratories, which they sold to Gilde Buy Out Partners in 2017. He holds several patents and authored a book about insects.
- Where does Bart Rossel work?
- Bart Rossel is Scientific Advisor and Advisory Board Member, Novalis Biotech Incubation Fund; Supervisory Board Member of Novalis at Novalis Biotech.
- What does Bart Rossel invest in?
- Bart Rossel invests in Biotech, Consumer.